Peptides having inhibiting activity on the production of nitric oxide

Details for Australian Patent Application No. 2002222675 (hide)

Owner FUJISAWA PHARMACEUTICAL CO., LTD.

Inventors Shima, Ichiro; Imamura, Kenichiro; Ohkawa, Takehiko; Ishibashi, Naoki; Sato, Kentaro

Agent Davies Collison Cave

Pub. Number AU-A-2002222675

PCT Pub. Number WO2002/055541

Priority PR 2371 02.01.01 AU; PR 7506 05.09.01 AU

Filing date 18 December 2001

Wipo publication date 24 July 2002

International Classifications

C07K 005/078 Peptides having up to four amino acids in a fully defined sequence

A61K 038/05 Medicinal preparations containing peptides - Dipeptides

A61P 009/00 Drugs for disorders of the cardiovascular system

A61P 011/00 Drugs for disorders of the respiratory system

A61P 037/00 Drugs for immunological or allergic disorders

C07K 005/06 Peptides having up to four amino acids in a fully defined sequence

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002222675

2 February 2006 Change of Name(s) of Applicant(s), Section 104

  Fujisawa Pharmaceutical Co., Ltd. The name of the applicant has been changed to Astellas Pharma, Inc.

16 August 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002222676-Preventives or remedies for endometriosis

2002222674